FDA Approves Cannabis Base Drug for Epilepsy

The Food and Drug Administration advisory panel unanimously recommended the approval of an epilepsy medication found in marijuana. The drug's active ingredient, cannabidiol, is one to the chemical compound found in the cannabis plant , but does not get people high. This will be the first cannabis derived prescription medicine available int he United States.

The drug Epidiolex, is made by GW Pharmaceuticals, a British company. This development underscores that there are medicinal properties in cannabidiol (CBD). GW Pharma had significant results for treating seizures associated with Lennox-Gastaut syndrome and Dravet syndrome. Although an increase risk of liver damage was flagged, the FDA thinks it can be managed.



"If we are not willing to give it to our family, it won't be sold to yours."


© 2019 CBDS Inc.   All Rights Reserved

*Our products should be used only as directed on the label. Consult with your physician or healthcare provider before use especially if you have a serious medical condition, use prescription medications, or are pregnant or nursing. These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease. By using this site, you agree to follow the Privacy Policy and all Terms & Conditions. Void Where Prohibited by Law. All trademarks and copyrights are property of their respective owners and are not affiliated with nor do they endorse this product.